Acumen Pharmaceuticals Financial Overview
Acumen Pharmaceuticals's market cap is currently $130.23M. The company's EPS TTM is $-0.44; its P/E ratio is -0.97; Acumen Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
